Pfizer Inc
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3056% above fair value
$30.52+0.57 (+1.90%)
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer Operating Lease Liabilities by Year
Operating Lease Liabilities — Total undiscounted future lease payments ($M) ($M)
Pfizer Operating Lease Liabilities: $3,199M in FY2025, up 0.1% from a year earlier.
Latest, FY2025
3,199
Period ended Dec 31, 2025
Change on a year earlier
+0.1%
3,197 in FY2024
History
7 years
Since FY2019
Sources
7
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-26) ↗
Reported in Form 10-K Lease Commitments Footnote.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Operating Lease Liabilities — Total undiscounted future lease payments ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3,199 | +0.1% | Form 10-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 3,197 | -16.4% | Form 10-K (filed 2025-02-27) ↗ |
| FY2023 | Dec 31, 2023 | 3,824 | -0.5% | Form 10-K (filed 2024-02-22) ↗ |
| FY2022 | Dec 31, 2022 | 3,844 | +6.2% | Form 10-K (filed 2023-02-23) ↗ |
| FY2021 | Dec 31, 2021 | 3,621 | +123.8% | Form 10-K (filed 2022-02-24) ↗ |
| FY2020 | Dec 31, 2020 | 1,618 | +5.8% | Form 10-K (filed 2021-02-25) ↗ |
| FY2019 | Dec 31, 2019 | 1,530 | – | Form 10-K (filed 2020-02-27) ↗ |
Cite this data
StockData. (2026). Pfizer Operating Lease Liabilities ($M), annual FY2019–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/lease-undisc-tot
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.